Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2025-12-26 @ 7:17 PM
Study NCT ID:
NCT05260359
Status:
COMPLETED
Last Update Posted:
2022-08-26
First Post:
2022-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dermal Irritation, Sensitization and Cumulative Irritation Potential of 6% Bemotrizinol
Sponsor:
DSM Nutritional Products, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-08
Completion Date Type:
ACTUAL
First Submit Date:
2022-02-11
First Submit QC Date:
None
Study First Post Date:
2022-03-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-25
Last Update Post Date:
2022-08-26
Last Update Post Date Type:
ACTUAL